Annovis Bio Announces Publication of Patents Covering the Treatment of Amyloid Lateral Sclerosis, Huntington’s Disease and Prion Diseases
News
Innervace Secures Up to $40 Million to Advance Novel Regenerative Medicine Platform for Neurological Disorders
Series A financing round, led by Deerfield Management, to accelerate a new cell therapy modality for the treatment of neurological disorders, including Parkinson’s Disease
Annovis Bio Announces First Patient Dosed in Phase 3 Trial in Patients with Early Parkinson’s Disease
Immunome Announces Publication in Clinical & Translational Immunology Highlighting B Cell Repertoires in Patients with Breast Cancer
– The study demonstrates the importance of tumor and lymph node-derived B cells for the discovery of antibodies directed at potentially novel targets
– The study results provide a framework for understanding the evolution of B cell families in cancer patients
Relmada Therapeutics Provides Corporate Update and Reports Second Quarter 2022 Financial Results
InfraScan Inc. Announces Publication of the Largest Study to date for TBI Diagnosis Utilizing NIRD
Duke Global Neurosurgery and Neurology publishes its independent results from the largest U.S.-based study using a near-infrared device (NIRD) to detect hemorrhage due to Traumatic Brain Injuries (TBI).
Relmada Therapeutics Receives FDA Fast Track Designation for REL-1017 as a Monotherapy for the Treatment of Major Depressive Disorder
Renovacor Reports Second Quarter 2022 Financial Results and Provides Corporate Update
REN-001 IND submission planned for the second half of 2022
Data from pilot pig study showing successful cardiac transduction with REN-001 delivered via low-dose retrograde coronary sinus infusion published in Journal of the American College of Cardiology: Basic to Translational Science